[RcouF1uZ4gsC]

>The findings, based on samples from more than 2,500 tumours and 38 cancer types, reveal a longer-than-expected window of opportunity in which patients could potentially be tested and treated at the earliest stages of the disease.

One issue with this might be selection bias towards cancer. What is the baseline rate of finding these type of mutations in people that do not develop cancer? There are cells going bad all the time in the human body, but because of factors such as the immune system, they actually don't cause any problems.

One example of this kind of thing is prostate cancer. Prostate cancer used to be aggressively treated often with a lot of side effects such as not being able to control urine and sexual dysfunction. However, further research showed that a lot of these cancers either don't continue to progress or progress so slowly that the patient will die with the cancer rather than from the cancer, and so not doing anything is the best course of action.

Overall this is an exciting development, but it will take a lot more research to know what should be done with that information, and to avoid over-treating which has its own downsides.